Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X:
“David Scott’s BC Cancer algorithm for treatment of newly-diagnosed DLBCL based on recent Canadian recommendation for polatuzumab reimbursement for ABC-subtype DLBCL.”
More posts featuring Eddie Cliff on OncoDaily.